HMGB1 - high mobility group box 1 Gene
Species: Oryctolagus cuniculus
Gene Type: protein coding
Gene ID: 100328641
HMGB1 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001171281.1 | NP_001164752.1 | high mobility group protein B1 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
high mobility group protein B1 |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(9)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-14519 | Methotrexate | Inhibitor | 99.95% | Yes |
| HY-N0184 | Glycyrrhizic acid | Inhibitor | 99.84% | Yes |
| HY-B0581 | Dexrazoxane | 99.88% | Yes | |
| HY-14519A | Methotrexate disodium | Inhibitor | 99.63% | Yes |
| HY-N0184A | Dipotassium glycyrrhizinate | Inhibitor | 99.68% | Yes |
| HY-14519B | Methotrexate hydrate | Inhibitor | 99.66% | Unkown |
| HY-N0184R | Glycyrrhizic acid (Standard) | Inhibitor | 97.54% | Unkown |
| HY-14519D | Methotrexate monohydrate | Inhibitor | / | Unkown |
| HY-121151 | (±)-Methotrexate | Inhibitor | / | Unkown |
Inhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P9928 | Alirocumab | Inhibitor | 97.00% | Unkown |
Clinical Phase
Bioactive Molecules
(4)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-Y1362 | Ethyl pyruvate | 99.87% | Phase 4 | |
| HY-P99813 | Patritumab deruxtecan | 99.08% | Phase 3 | |
| HY-10447 | Terameprocol | 99.50% | Phase 2 | |
| HY-113402B | Gamma-glutamylcysteine ammonium | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(59)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-101872 | GSK-872 | Inhibitor | 99.91% | Unkown |
| HY-113402 | Gamma-glutamylcysteine | 98.53% | Unkown | |
| HY-P990117 | Anti-Mouse/Rat/Human Osteopontin/SPP1 Antibody (MPIIIB10) | Inhibitor | 95.00% | Unkown |
| HY-14307 | Necrocide 1 | 99.55% | Unkown | |
| HY-101872A | GSK-872 hydrochloride | Inhibitor | 98.85% | Unkown |
| HY-111815A | N4-Acetylcytidine triphosphate sodium | / | Unkown | |
| HY-P2268 | RAGE antagonist peptide | Antagonist | 98.16% | Unkown |
| HY-162065 | N6F11 | Inducer | 98.08% | Unkown |
| HY-W019670 | N4-Acetylcytidine | 99.65% | Unkown | |
| HY-N0535 | (+)-Magnoflorine chloride | 99.29% | Unkown | |
| HY-148226 | 20-5,14-HEDGE | 99.28% | Unkown | |
| HY-P3042 | Chymostatin | Inhibitor | 99.9% | Unkown |
| HY-113772 | Inflachromene | Inhibitor | 99.76% | Unkown |
| HY-N0334A | (+)-Magnoflorine iodide | 99.74% | Unkown | |
| HY-113402A | Gamma-glutamylcysteine TFA | 96.68% | Unkown | |
| HY-N0442 | 5-O-Methylvisammioside | Inhibitor | 99.90% | Unkown |
| HY-124750 | NecroX-7 | Inhibitor | 99.69% | Unkown |
| HY-N1508 | Ecliptasaponin A | 99.81% | Unkown | |
| HY-N2055 | Kaempferol 3-O-sophoroside | 99.41% | Unkown | |
| HY-156675A | Plecstatin-1 hydrochloride | 98.96% | Unkown | |
| HY-W017180 | 2-(Bromomethyl)acrylic acid | 97.51% | Unkown | |
| HY-14519S | Methotrexate-d3 | Inhibitor | 99.83% | Unkown |
| HY-P2268A | RAGE antagonist peptide TFA | Antagonist | 99.41% | Unkown |
| HY-172279A | DSPE-PEG2000-TAT | 95.0% | Unkown | |
| HY-155751 | HMGB1-IN-1 | Inhibitor | 98.40% | Unkown |
| HY-113402R | Gamma-glutamylcysteine (Standard) | 98.14% | Unkown | |
| HY-N0772 | Isomangiferin | 99.60% | Unkown | |
| HY-163409 | CGK012 | Inhibitor | 99.96% | Unkown |
| HY-N0320 | Salvianolic acid D | 95.15% | Unkown | |
| HY-RS06232 | HMGB1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-N3097 | Pellitorine | 99.84% | Unkown | |
| HY-W753593 | N4-Acetylcytidine-13C5 | 95.92% | Unkown | |
| HY-111815 | N4-Acetylcytidine triphosphate | / | Unkown | |
| HY-14519S1 | Methotrexate-d3 diammonium | Inhibitor | 99.69% | Unkown |
| HY-156675 | Plecstatin-1 | / | Unkown | |
| HY-177414 | BB-1701 | 98.81% | Unkown | |
| HY-113402AR | Gamma-glutamylcysteine TFA (Standard) | 95.17% | Unkown | |
| HY-N0334 | (+)-Magnoflorine | / | Unkown | |
| HY-121151S | (±)-Methotrexate-d3 | Inhibitor | / | Unkown |
| HY-121151S2 | (±)-Methotrexate-13C,d3 disodium | Inhibitor | / | Unkown |
| HY-143456 | Anti-inflammatory agent 18 | Inhibitor | / | Unkown |
| HY-143457 | Anti-inflammatory agent 19 | Inhibitor | / | Unkown |
| HY-155759 | HMGB1-IN-2 | Inhibitor | / | Unkown |
| HY-168650 | ROCK/HDAC-IN-1 | Inhibitor | / | Unkown |
| HY-184943 | Pan-PDK degrader-1 | / | Unkown | |
| HY-19421 | Orazamide | Inhibitor | / | Unkown |
| HY-N9587 | Tricin 7-O-β-D-glucopyranoside | Inducer | 99.23% | Unkown |
| HY-P10321 | HBP08 | / | Unkown | |
| HY-P11549 | pPB peptide | Ligand | / | Unkown |
| HY-P5762A | Phoenixin-14 TFA | / | Unkown | |
| HY-110051 | DPP4-In hydrochloride | / | Unkown | |
| HY-167182 | PUMAi | Inhibitor | / | Unkown |
| HY-168053 | HMGB1-IN-3 | Inhibitor | / | Unkown |
| HY-182824 | Sucrose dilaurate | Inducer | / | Unkown |
| HY-N0442R | 5-O-Methylvisammioside (Standard) | Inhibitor | / | Unkown |
| HY-N20719 | Vulgarin | Inhibitor | / | Unkown |
| HY-RS16500 | Hmgb1 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS22930 | Hmgb1 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS25102 | Hbp1 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Inhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P9928A | Alirocumab (anti-PCSK9) | Inhibitor | 98.24% | Unkown |